{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T21:57:21Z","timestamp":1769291841440,"version":"3.49.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]},{"name":"Science, Humanities, Technology and Innovation Secretary (SECIHTI).","award":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""],"award-info":[{"award-number":["Project 3019 \"Emerging drugs in the northern border: From diagnosis to community intervention\""]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01355-0","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T12:34:49Z","timestamp":1766147689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fentanyl, Amphetamine-type Stimulants, Heroin, and xylazine in drug residues in two Northern border Mexican cities"],"prefix":"10.1186","volume":"23","author":[{"given":"Clara Fleiz","family":"Bautista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Elena","family":"Medina-Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia L.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"L\u00f3pez-Brambila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valent\u00edn","family":"Miranda-Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Said","family":"Slim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"4","key":"1355_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/add.14934","volume":"115","author":"C Fleiz","year":"2020","unstructured":"Fleiz C, Arredondo J, Ch\u00e1vez A, Pacheco L, Segovia LA, Villatoro JA, et al. Fentanyl is used in Mexico\u2019s northern border: current challenges for drug health policies. Addiction. 2020;115(4):778\u201381.","journal-title":"Addiction"},{"issue":"14","key":"1355_CR2","doi-asserted-by":"publisher","first-page":"E469","DOI":"10.1503\/cmaj.231339","volume":"196","author":"S Ledlie","year":"2024","unstructured":"Ledlie S, Juurlink DN, Tadrous M, Mamdani M, Paterson JM, Gomes T. Opioid-related deaths between 2019 and 2021 across 9 Canadian provinces and territories. CMAJ. 2024;196(14):E469\u201376. https:\/\/doi.org\/10.1503\/cmaj.231339.","journal-title":"CMAJ"},{"key":"1355_CR3","unstructured":"Canadian Criminal Intelligence Service. Summary\u20142024 public report on organized crime [Internet]. Ottawa: Criminal Intelligence Service Canada; 3 Dec 2024 [cited 5 Sep 2025]. Available from: https:\/\/cisc-scrc.gc.ca\/media\/2024\/2024-12-03-eng.htm"},{"key":"1355_CR4","doi-asserted-by":"publisher","unstructured":"Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts. https:\/\/doi.org\/10.15620\/cdc\/20250305008","DOI":"10.15620\/cdc\/20250305008"},{"key":"1355_CR5","doi-asserted-by":"crossref","unstructured":"Malayala S, Papudesi B, BR, WA. Xylazine-Induced Skin ulcers in a person who injects drugs in Philadelphia, Pennsylvania, USA. Cureus. 2022; 14(8).","DOI":"10.7759\/cureus.28160"},{"issue":"5","key":"1355_CR6","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/add.14474","volume":"114","author":"SG Mars","year":"2019","unstructured":"Mars SG, Rosenblum D, Ciccarone D. Illicit fentanyls in the opioid street market: desired or imposed? Addiction. 2019;114(5):774\u201380. https:\/\/doi.org\/10.1111\/add.14474.","journal-title":"Addiction"},{"issue":"19","key":"1355_CR7","volume":"3","author":"B Fischer","year":"2023","unstructured":"Fischer B. The continuous opioid death crisis in Canada: changing characteristics and implications for path options forward. Lancet Reg Health Am. 2023;3(19):100437.","journal-title":"Lancet Reg Health Am"},{"key":"1355_CR8","unstructured":"Ahmad F, Cisewski J, Rossen L, P S. Provisional drug overdose death counts. 2025. [Internet]. [cited 2025 March 6]. Available from: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.html."},{"key":"1355_CR9","unstructured":"Government of Canada. Canada. 2023. Spotlight: the evolution of fentanyl in Canada over the past 11 years [Internet]. [cited 2025 Mar 6]. Available from: https:\/\/insightcrime.org\/wp-content\/uploads\/2023\/08\/evolution-fentanyl-canada-11-years-en.pdf."},{"issue":"4","key":"1355_CR10","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/cid\/ciae372","volume":"79","author":"JR Friedman","year":"2024","unstructured":"Friedman JR, Abramovitz D, Skaathun B, Rangel G, Harvey Vera A, Vera CF, et al. Illicit fentanyl use and hepatitis C virus seroconversion among people who inject drugs in Tijuana and San Diego: results from a binational cohort study. Clin Infect Dis. 2024;79(4):1109\u201316. https:\/\/doi.org\/10.1093\/cid\/ciae372.","journal-title":"Clin Infect Dis"},{"key":"1355_CR11","unstructured":"Fleiz-Bautista C, Dom\u00ednguez-Garc\u00eda M, Villatoro-Vel\u00e1zquez JA, V\u00e1zquez-Quiroz F, Zafra-Mora E, S\u00e1nchez-Ramos R, Medina-Mora ME. Cuqueando la Chiva: Contextos del consumo de hero\u00edna en la frontera norte de M\u00e9xico. Ciudad de M\u00e9xico, M\u00e9xico: Instituto Nacional de Psiquiatr\u00eda Ram\u00f3n de la Fuente Mu\u00f1iz. 2019."},{"issue":"103678","key":"1355_CR12","first-page":"1","volume":"104","author":"J Friedman","year":"2022","unstructured":"Friedman J, Bourgois P, Godvin M, Chavez A, Pacheco L, Segovia LA, et al. The introduction of fentanyl on the US\u2013Mexico border: an ethnographic account triangulated with drug checking data from Tijuana. Int J Drug Policy. 2022;104(103678):1\u201319.","journal-title":"Int J Drug Policy"},{"key":"1355_CR13","unstructured":"Comisi\u00f3n Nacional de Salud Mental y Adicciones (CONASAMA); Secretar\u00eda de Salud. Informe de la demanda y oferta de Fentanilo en M\u00e9xico: generalidades y situaci\u00f3n actual. 2024. [Internet]. [cited 2025 Mar 6]. Available from: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/910633\/Informe_Fentanilo_abril_2024.pdf"},{"issue":"7","key":"1355_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2105\/AJPH.2024.307650","volume":"114","author":"RM Henson","year":"2024","unstructured":"Henson RM, Mullachery PH, S\u00e1nchez-P\u00e1jaro A, Cruz-Cruz C, Bilal U, Langellier B, et al. Spatial heterogeneity in fatal overdose rate trends in Mexican cities: 2005\u20132021. Am J Public Health. 2024;114(7):705\u201313.","journal-title":"Am J Public Health"},{"key":"1355_CR15","unstructured":"British Columbia Centre on Substance Use (BCCSU). Trends in drug checking results across British Columbia: Jan to Dec 2023. Vancouver: BCCSU; 2024. Available from: https:\/\/drugcheckingbc.ca\/reports\/"},{"key":"1355_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12954-023-00921-8","volume":"21","author":"JC Halifax","year":"2024","unstructured":"Halifax JC, Lim L, Ciccarone D, et al. Testing the test strips: laboratory performance of fentanyl test strips. Harm Reduct J. 2024;21:14.","journal-title":"Harm Reduct J"},{"key":"1355_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102661","volume":"77","author":"TC Green","year":"2020","unstructured":"Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, et al. An assessment of the limits of detection, sensitivity and specificity of fentanyl test strips across matrices. Int J Drug Policy. 2020;77:102661. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102661.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"1355_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z","volume":"44","author":"AG Glaros","year":"1988","unstructured":"Glaros AG, Kline RB. Understanding the accuracy of tests with cutting scores: the sensitivity, specificity, and predictive value model. J Clin Psychol. 1988;44(6):1013\u20131023.","journal-title":"J Clin Psychol."},{"issue":"3","key":"1355_CR19","first-page":"118","volume":"97","author":"K Humphreys","year":"2018","unstructured":"Humphreys K, Caulkins J, Felbab-Brown V. Opioids of the masses: stopping an American epidemic from going global. Foreign Aff. 2018;97(3):118\u201329.","journal-title":"Foreign Aff"},{"key":"1355_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103086","volume":"94","author":"P Reuter","year":"2021","unstructured":"Reuter P, Pardo B, Taylor J. Imagining a fentanyl future: Some consequences of synthetic opioids replacing heroin. Int J Drug Policy. 2021;94:103086.","journal-title":"Int J Drug Policy"},{"issue":"236","key":"1355_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2022.109478","volume":"1","author":"PO Coffin","year":"2022","unstructured":"Coffin PO, Maya S, Kahn JG. Modeling of overdose and naloxone distribution in the setting of fentanyl compared to heroin. Drug Alcohol Depend. 2022;1(236):109478. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109478. (PubMed PMID: 35588609).","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"1355_CR22","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1080\/15563650.2022.2063135","volume":"60","author":"NS Ball","year":"2022","unstructured":"Ball NS, Knable BM, Relich TA, Smathers AN, Gionfriddo MR, Nemecek BD, et al. Xylazine poisoning: a systematic review. Clin Toxicol. 2022;60(8):892\u2013901.","journal-title":"Clin Toxicol"},{"issue":"3","key":"1355_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11524-011-9662-6","volume":"89","author":"JC Reyes","year":"2012","unstructured":"Reyes JC, Negr\u00f3n JL, Col\u00f3n HM, Padilla AM, Mill\u00e1n MY, Matos TD, et al. The emerging of xylazine as a new drug of abuse and its health consequences among drug users in Puerto Rico. J Urban Health. 2012;89(3):519\u201326.","journal-title":"J Urban Health"},{"issue":"4","key":"1355_CR24","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/injuryprev-2020-043968","volume":"27","author":"J Johnson","year":"2021","unstructured":"Johnson J, Pizzicato L, Johnson C, Viner K. Increasing presence of xylazine in heroin and\/or fentanyl deaths, Philadelphia, Pennsylvania, 2010-2019. Inj Prev. 2021;27(4):395\u20138.","journal-title":"Inj Prev"},{"key":"1355_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jdcr.2023.04.010","volume":"36","author":"L Rose","year":"2023","unstructured":"Rose L, Kirven R, Tyler K, Chung C, Korman AM. Xylazine-induced acute skin necrosis in two patients who inject fentanyl. JAAD Case Rep. 2023;36:113\u20135.","journal-title":"JAAD Case Rep"},{"key":"1355_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.110993","volume":"253","author":"P Acosta-Mares","year":"2023","unstructured":"Acosta-Mares P, Violante-Soria V, Browne T, Cruz S. Xylazine potentiates the lethal but not the rewarding effects of fentanyl in mice. Drug Alcohol Depend. 2023;253:110993.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"1355_CR27","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s00213-023-06390-y","volume":"240","author":"S Choi","year":"2023","unstructured":"Choi S, Irwin M, Kiyatkin E. Xylazine effects on opioid-induced brain hypoxia. Psychopharmacology. 2023;240(7):1561\u201371.","journal-title":"Psychopharmacology"},{"key":"1355_CR28","unstructured":"Center for Forensic Science Research and Education (CFSRE). Xylazine: A toxic adulterant found in illicit street drugs. 2020. [Internet]. [cited 2025 Mar 6]. Available from: https:\/\/www.cfsre.org\/nps-discovery\/public-alerts\/xylazine-a-toxic-adulterant-found-in-illicit-street-drugs."},{"key":"1355_CR29","unstructured":"Canadian Centre on Substance Use and Addiction (CCSA). Canadian community epidemiology network on drug use (CCENDU). 2022. [Internet]. [cited 2025 Mar 6]. Available from: https:\/\/www.ccsa.ca\/en\/data-trends\/ccendu"},{"key":"1355_CR30","unstructured":"Comisi\u00f3n Nacional de Salud Mental y Adicciones (CONASAMA). 2024. [Internet]. [cited 2025 March 6]. Available from: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/906959\/SAT._Alerta_en_ciudades_fronterizas_por_uso_de_Xilacina.pdf"},{"issue":"1","key":"1355_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12954-022-00588-7","volume":"19","author":"RW Harding","year":"2022","unstructured":"Harding RW, Wagner KT, Fiuty P, Smith KP, Page K, Wagner KD. \u201cIt\u2019s called overamping\u201d: experiences of overdose among people who use methamphetamine. Harm Reduct J. 2022;19(1):4.","journal-title":"Harm Reduct J"},{"issue":"4","key":"1355_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr Opin Psychiatry. 2021;34(4):344\u201350.","journal-title":"Curr Opin Psychiatry"},{"issue":"14","key":"1355_CR33","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/jama.2022.2847","volume":"327","author":"J Friedman","year":"2022","unstructured":"Friedman J, Godvin M, Shover CL, Gone JP, Hansen H, Schriger DL. Trends in drug overdose deaths among US adolescents, january 2010 to june 2021. JAMA. 2022;327(14):1398\u2013400.","journal-title":"JAMA"},{"issue":"1","key":"1355_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurpra.2023.104858","volume":"20","author":"P Wilson","year":"2024","unstructured":"Wilson P, Day T. Benzodiazepine withdrawal in the context of Benzodiazepine-contaminated opioids: practice implications. J Nurse Pract. 2024;20(1):104858.","journal-title":"J Nurse Pract"},{"key":"1355_CR35","unstructured":"Jim\u00e9nez A. Advierte IPEBC uso de medicamentos sin receta. La Voz de la Frontera. 2024. [Internet]. [cited 2025 Mar 6]. Available from: https:\/\/oem.com.mx\/lavozdelafrontera\/local\/advierte-ipebc-uso-de-medicamentos-sin-receta-13137243."},{"issue":"Pt 4","key":"1355_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","volume":"134","author":"P Armenian","year":"2018","unstructured":"Armenian P, Vo K, Barr-Walker J, Lynch K. Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology. 2018;134(Pt 4):121\u201332.","journal-title":"Neuropharmacology"},{"issue":"3","key":"1355_CR37","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/dar.13580","volume":"42","author":"H Crepeault","year":"2023","unstructured":"Crepeault H, Socias M, Tobias S, Lysyshyn M, Custance A, Shapiro A, et al. Examining fentanyl and its analogues in the unregulated drug supply of British Columbia, Canada using drug checking technologies. Drug Alcohol Rev. 2023;42(3):538\u201343.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"1355_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41398-023-02406-5","volume":"13","author":"M Milella","year":"2023","unstructured":"Milella M, D\u2019Ottavio G, De Pirro S, Barra M, Caprioli D, Badiani A. Heroin and its metabolites: relevance to heroin use disorder. Transl Psychiatry. 2023;13(1):120.","journal-title":"Transl Psychiatry"},{"issue":"5","key":"1355_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/biology11050672","volume":"11","author":"R Tittarelli","year":"2022","unstructured":"Tittarelli R, Gismondi A, Di Marco G, Mineo F, Vernich F, Russo C, et al. Forensic application of genetic and toxicological analyses for the identification and characterization of the opium poppy (Papaver somniferum L.). Biology. 2022;11(5):672.","journal-title":"Biology"},{"key":"1355_CR40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.fsisyn.2020.06.004","volume":"2","author":"I Onoka","year":"2020","unstructured":"Onoka I, Banyika AT, Banerjee PN, Makangara JJ, Dujourdy L. A review of the newly identified impurity profiles in methamphetamine seizures. Forensic Sci Int Synergy. 2020;2:194\u2013205.","journal-title":"Forensic Sci Int Synergy"},{"key":"1355_CR41","volume":"22","author":"A Hern\u00e1ndez","year":"2021","unstructured":"Hern\u00e1ndez A. Flujos, contrabando y pr\u00e1cticas de ilegalidad en la frontera M\u00e9xico Estados Unidos: cruces fronterizos entre Tijuana y San Diego. Estud Front. 2021;22:e077.","journal-title":"Estud Front"},{"key":"1355_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.103065","volume":"90","author":"MSS Bergh","year":"2021","unstructured":"Bergh MSS, \u00d8iestad \u00c5ML, Baumann MH, Bogen IL. Selectivity and sensitivity of urine fentanyl test strips to detect fentanyl analogues in illicit drugs. Int J Drug Policy. 2021;90:103065. https:\/\/doi.org\/10.1016\/j.drugpo.2020.103065.","journal-title":"Int J Drug Policy"},{"key":"1355_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12954-021-00478-4","volume":"18","author":"TLE Lockwood","year":"2021","unstructured":"Lockwood TLE, Vervoordt A, Lieberman M. High concentrations of illicit stimulants and cutting agents cause false positives on fentanyl test strips. Harm Reduct J. 2021;18:30. https:\/\/doi.org\/10.1186\/s12954-021-00478-4.","journal-title":"Harm Reduct J"},{"key":"1355_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2022.111420","volume":"338","author":"JN Park","year":"2022","unstructured":"Park JN, Sherman SG, Sigmund V, Breaud A, Martin K, Clarke WA. Validation of a lateral flow chromatographic immunoassay for the detection of fentanyl in drug samples. Forensic Sci Int. 2022;338:111420. https:\/\/doi.org\/10.1016\/j.forsciint.2022.111420.","journal-title":"Forensic Sci Int"},{"key":"1355_CR45","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12954-023-00777-6","volume":"20","author":"L Gozdzialski","year":"2023","unstructured":"Gozdzialski L, McCrae K, Tobias S, Scheim A, Buxton J, Scarfone K, et al. Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations. Harm Reduct J. 2023;20:24. https:\/\/doi.org\/10.1186\/s12954-023-00777-6.","journal-title":"Harm Reduct J"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01355-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:16:29Z","timestamp":1769170589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12954-025-01355-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1355"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01355-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}